While peripheral administration of CRH aggravated IBD-associated body weight loss, DAI score, and change in colon length, blocking the autophagy process with chloroquine significantly alleviated IBD-associated changes in body weight loss and DAI score, but not the change in colon length (Fig. 5A–C). Here, CRH is linked to inflammatory bowel disease.